Artelo Biosciences Reports Positive Pre-clinical Results for Lead Program in Cancer-Related Cachexia
New Research from Trinity College Dublin Indicates Broader Therapeutic Potential for ART27.13 SOLANA BEACH, Calif.,…
News
Epygen Biotech Announces Funding from India Government for Development of a COVID-19 Vaccine Using Dyadic’s Licensed C1 Protein Production Platform
India’s Department of Biotechnology, Government of India to support scale up and production of cGMP batches of SARS-CoV-2…
Nuvectis Pharma Recaps Poster Presentation Highlights for NXP900 at the 2022 American Association for Cancer Research (AACR) Conference
Fort Lee, NJ, April 13, 2022 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc (NASDAQ: NVCT), (“Nuvectis”…
IN8bio Continues to Build on its Clinical and Regulatory Team with Two Key Appointments
Urvashi Patel, Ph.D., as Vice President, Regulatory Affairs Stacey Bilinski, as Vice President, Clinical Operations…
Oncternal Therapeutics Deprioritizes Development of ONCT-216 to Focus Resources on Phase 3 Trial for Zilovertamab in the Treatment of Mantle Cell Lymphoma
Discontinued enrollment of Phase 1/2 trial of ONCT-216 in Ewing sarcoma Resources will be primarily…
ExCellThera announces new publication showing its ECT-001 cell therapy improves transplant access for all patients
MONTREAL, April 13, 2022 (GLOBE NEWSWIRE) — ExCellThera Inc. (ExCellThera), an advanced clinical-stage biotechnology company…
First Cigarette That “Helps You Smoke Less” Launches National Pilot in Chicagoland
VLN® Reduced Nicotine Content Cigarettes Launch in Chicagoland Pilot VLN® 95% reduced nicotine content cigarettes…
Renibus Therapeutics Strengthens IP Position with Additional US Patent
Renibus Therapeutics granted patent approval for the novel aqueous iron composition of RBT-3, a product…
aTyr Pharma Announces FDA Orphan Drug Designation for Efzofitimod (ATYR1923) for Treatment of Systemic Sclerosis
Second U.S. orphan drug designation for efzofitimod clinical program SAN DIEGO, April 13, 2022 (GLOBE…
Aquestive Therapeutics Announces Common Stock Purchase Agreement for up to $40 Million with Lincoln Park Capital
Provides Access to Additional Capital to Support Growth WARREN, N.J., April 13, 2022 (GLOBE NEWSWIRE)…
Applied Molecular Transport Announces Publication in Tissue Barriers Providing Additional Insight into Company’s Proprietary Technology Platform
Publication describes critical interactions between cholix-based transport domain and endogenous intracellular trafficking pathways used by…
Recce Pharmaceuticals Announces Phase I Clinical Trial of RECCE® 327 Advances to High Dosing Level
Dose increase of R327 Dose increase of R327 Highlights: 36 subjects successfully dosed in Phase…
Praxis Precision Medicines to Host Epilepsy Day on April 27, 2022
BOSTON, April 13, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
Baudax Bio to Present at NobleCon18 Investor Conference
MALVERN, Pa., April 13, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company…
Longeveron Enters into Cooperative Research and Development Agreement with the US Department of Veterans Affairs for its Phase 2 Alzheimer’s Trial
This third collaboration with the Miami VA shows Longeveron’s commitment to improving the health of…
Repligen to Report First Quarter 2022 Financial Results
Webcast and Conference Call to Be Held Wednesday, April 27, 2022 at 8:30 a.m. EDT…
Renowned Wound Care Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Spring
Additional data covered a variety of specialties, including vascular surgery, plastic surgery, general surgery, and…
Theratechnologies Reports Financial Results for First Quarter Fiscal 2022 and Provides Business Update
– Q1 2022 consolidated sales grew 20%, supported by 35% growth in EGRIFTA SV®sales –…
iSpecimen Adds Acutis Diagnostics to Marketplace Platform to Support Oncology and Infectious Disease Research
The iSpecimen Marketplace Platform Now Provides Custom Sequencing for Cancer and COVID-19 Biofluid and Tissue…
ProQR Announces Additional Sepofarsen Illuminate Trial Analyses and Provides Update on Company Strategy
Post-hoc analyses from Illuminate trial of sepofarsen demonstrate an encouraging efficacy signal when comparing active…